For example: Apple Inc, UTIL, Aluminum
Owens & Minor Inc
NYSE:OMI
Market Close 11/27
24.91 USD -0.22 (-0.88%)
OPEN:
25.26
DAY RANGE:
23.57 - 25.55
PE:
-0.67
PB:
0.76
PS:
0.02
WTD % 7.00
MTD % -0.84
QTD % -0.80
YTD % 381.82
* Updated at market close
Owens & Minor Inc (NYSE:OMI) opened on Nov 27, 2020 at 25.26 USD and went marginally down by -0.88%. The intraday price range was 23.57 - 25.55 USD and eventually ended the session at 24.91 USD. The stock trade volume was 1.15 M shares. The company's 52-week range is 3.63 - 27.75 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 1.59 B
Outstanding Stock 62.27 M
Dividend 0.00
Dividend Yield 10.60%
EPS -4.78
YTD Change 381.82%
52 Week's Range 3.63 - 27.75
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning -0.67
Price/Book Value 0.76
Price/Sales 0.02
ROA -
ROE -
Debt/Equity 6.84
Company Self Description
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices. Its service portfolio consists of procurement, inventory management, delivery, and sourcing of products for the healthcare market; and portfolio of medical and surgical supplies comprises branded products purchased from manufacturers and proprietary private-label products. It was founded in 1882 and is headquartered in Mechanicsville, Virginia, United States.
Business Information
Owens & Minor Inc
Sector Health Care
Industry Health Care Providers & Services
Exchange NYSE
Top Competitors (Market Close Nov 27, 2020)
  OMI ADUS CRVL MD
Daily Change (%) -0.88 0.20 -0.79 -1.23
WTD (%) 7.00 0.80 -0.94 0.85
MTD (%) -0.84 -1.35 0.31 57.73
QTD (%) -0.80 1.84 7.11 23.53
YTD (%) 381.82 -1.00 4.74 -27.64
52-Week Change (%) 278.00 1.61 10.99 -24.03
Stock Performance (Market Close Nov 27, 2020)
  OMI ADUS CRVL MD
Daily Change (%) -0.88 0.20 -0.79 -1.23
WTD (%) 7.00 0.80 -0.94 0.85
MTD (%) -0.84 -1.35 0.31 57.73
QTD (%) -0.80 1.84 7.11 23.53
YTD (%) 381.82 -1.00 4.74 -27.64
52-Week Change (%) 278.00 1.61 10.99 -24.03
Key Fundamentals (Market Close Nov 27, 2020)
  OMI ADUS CRVL MD
Market Cap 1.59 B 1.51 B 1.64 B 1.72 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -2.90% 3.30% 8.10% -3.50%
P/E Ratio -0.67 51.69 33.73 -16.71
Price to Sales Ratio 0.02 1.73 2.71 0.59
Price to Book Ratio 0.76 3.23 6.24 0.96
Enterprise Value to EBITDA -6.58 23.64 12.74 8.62
ROA - 4.80% 14.10% -2.20%
ROE - 6.70% 24.80% -4.30%
Debt/Equity 6.84 0.29 0.63 0.92
Asset Turnover Ratio 2.56 1.44 1.74 0.61
Current Ratio 1.73 3.02 1.84 1.31
Dividend Yield 10.60% 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 9.84 B 9.32 B 9.72 B 9.77 B
Cost Of Revenue 8.47 B 8.15 B 8.54 B 8.56 B
Gross Profit 1.37 B 1.17 B 1.19 B 1.21 B
Selling General & Administrative Expenses 1.26 B 1.02 B 970.42 M 993.78 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income -392.17 M 89.25 M 199.60 M 200.36 M
Net Income -437.01 M 72.79 M 108.79 M 103.41 M
EPS -7.28 1.20 1.76 1.65
Diluted EPS -7.28 1.20 1.76 1.65
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 2.48 B 2.46 B 2.54 B 2.46 B
Cost Of Revenue 2.12 B 2.10 B 2.18 B 2.11 B
Gross Profit 368.43 M 358.42 M 364.71 M 352.57 M
Selling General & Administrative Expenses 345.89 M 338.70 M 343.60 M 325.01 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income 16.14 M 14.69 M -265.70 M 21.36 M
Net Income -10.48 M -14.10 M -261.82 M -565,000.00
EPS -0.18 -0.23 -4.36 -0.01
Diluted EPS -0.18 -0.23 -4.36 -0.01
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 2.54 B 2.18 B 1.96 B 1.97 B
Cash & Cash Equivalents 103.37 M 104.52 M 185.49 M 161.02 M
Total Assets 3.77 B 3.38 B 2.72 B 2.77 B
Total Current Liabilities 1.47 B 1.31 B 1.03 B 1.06 B
Total Liabilities 3.26 B 2.36 B 1.76 B 1.78 B
Shareholder's Equity 518.42 M 1.02 B 960.04 M 992.59 M
Outstanding Stock 62.27 M 61.25 M 61.51 M 62.89 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 2.47 B 2.47 B 2.54 B 2.49 B
Cash & Cash Equivalents 91.34 M 75.24 M 103.37 M 124.89 M
Total Assets 3.90 B 3.88 B 3.77 B 4.03 B
Total Current Liabilities 1.47 B 1.41 B 1.47 B 1.46 B
Total Liabilities 3.40 B 3.38 B 3.26 B 3.24 B
Shareholder's Equity 496.90 M 501.84 M 518.42 M 792.41 M
Outstanding Stock 62.94 M 62.24 M 62.27 M 62.32 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 115.59 M 56.77 M 187.70 M 270.24 M
Capital Expenditures -64.00 M -50.07 M -24.75 M -36.47 M
Net Cash Flow from Investing Activities -815.83 M -416.64 M -24.75 M -36.47 M
Net Cash Flow from Financial Activities 701.07 M 272.81 M -142.70 M -124.88 M
Free Cash Flow 51.59 M 6.70 M 162.95 M 233.77 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 89.92 M 56.77 M 187.70 M 270.24 M
Capital Expenditures -11.18 M -14.01 M -16.95 M -17.01 M
Net Cash Flow from Investing Activities -11.18 M -14.01 M -16.95 M -35.41 M
Net Cash Flow from Financial Activities -65.56 M 49.51 M 5.91 M -31.68 M
Free Cash Flow 78.73 M -74.91 M -23.87 M 59.25 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -0.67 -0.54 -0.87 -6.43
Price to Sales Ratio 0.02 0.03 0.04 0.11
Price to Book Ratio 0.76 1.14 2.26 2.28
Enterprise Value to EBIT -5.00 22.00 13.00 14.00
Enterprise Value to EBITDA -6.58 13.28 9.90 10.18
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -11.50% 2.40%
ROE - - -55.80% 7.30%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 1.07 B 872.17 M 927.40 M 911.11 M
Current Ratio 1.73 1.67 1.90 1.86
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 6.84 2.33 1.83 1.79
Asset Turnover Ratio - - 2.58 3.05
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.